IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 213 filers reported holding IMMUNOGEN INC in Q3 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $25,482,681 | -52.6% | 1,605,714 | -43.6% | 0.01% | -50.0% |
Q2 2023 | $53,739,175 | +361390.5% | 2,847,863 | -26.4% | 0.03% | +188.9% |
Q1 2023 | $14,866 | +142.9% | 3,871,424 | +213.8% | 0.01% | +125.0% |
Q4 2022 | $6,119 | -99.9% | 1,233,720 | -50.7% | 0.00% | -42.9% |
Q3 2022 | $11,964,000 | -49.4% | 2,503,037 | -52.4% | 0.01% | -53.3% |
Q2 2022 | $23,657,000 | +38.1% | 5,257,049 | +46.0% | 0.02% | +66.7% |
Q1 2022 | $17,136,000 | -55.2% | 3,600,017 | -30.1% | 0.01% | -52.6% |
Q4 2021 | $38,208,000 | +121.1% | 5,149,291 | +69.0% | 0.02% | +90.0% |
Q3 2021 | $17,279,000 | -3.7% | 3,047,521 | +11.9% | 0.01% | -9.1% |
Q2 2021 | $17,944,000 | -7.4% | 2,722,908 | +13.8% | 0.01% | -21.4% |
Q1 2021 | $19,378,000 | +53.8% | 2,392,301 | +22.5% | 0.01% | +55.6% |
Q4 2020 | $12,600,000 | -26.4% | 1,953,474 | -58.9% | 0.01% | -57.1% |
Q3 2020 | $17,119,000 | -6.6% | 4,755,374 | +19.3% | 0.02% | -16.0% |
Q2 2020 | $18,336,000 | +171.8% | 3,985,994 | +101.5% | 0.02% | +66.7% |
Q1 2020 | $6,746,000 | -55.5% | 1,978,258 | -33.4% | 0.02% | -21.1% |
Q4 2019 | $15,160,000 | +160.7% | 2,969,579 | +23.6% | 0.02% | +111.1% |
Q3 2019 | $5,814,000 | -0.7% | 2,402,854 | -10.9% | 0.01% | 0.0% |
Q2 2019 | $5,855,000 | -33.6% | 2,698,055 | -17.1% | 0.01% | -30.8% |
Q1 2019 | $8,820,000 | -69.0% | 3,254,576 | -45.0% | 0.01% | -70.5% |
Q4 2018 | $28,417,000 | +258.4% | 5,920,360 | +607.2% | 0.04% | +340.0% |
Q3 2018 | $7,928,000 | +178.8% | 837,142 | +186.5% | 0.01% | +233.3% |
Q2 2018 | $2,844,000 | -84.1% | 292,204 | -82.8% | 0.00% | -87.5% |
Q1 2018 | $17,857,000 | -5.3% | 1,697,382 | -42.3% | 0.02% | -7.7% |
Q4 2017 | $18,855,000 | -34.9% | 2,941,487 | -22.3% | 0.03% | -40.9% |
Q3 2017 | $28,974,000 | +1.1% | 3,787,427 | -6.0% | 0.04% | -13.7% |
Q2 2017 | $28,649,000 | +568.9% | 4,029,457 | +264.1% | 0.05% | +537.5% |
Q1 2017 | $4,283,000 | -5.3% | 1,106,695 | -50.1% | 0.01% | -11.1% |
Q4 2016 | $4,525,000 | -6.9% | 2,218,350 | +22.3% | 0.01% | +12.5% |
Q3 2016 | $4,862,000 | -2.8% | 1,814,320 | +11.7% | 0.01% | -27.3% |
Q2 2016 | $5,003,000 | +1091.2% | 1,624,508 | +5152.9% | 0.01% | +1000.0% |
Q4 2015 | $420,000 | -97.2% | 30,926 | -98.0% | 0.00% | -96.6% |
Q3 2015 | $14,930,000 | -73.8% | 1,555,230 | -60.8% | 0.03% | -73.1% |
Q2 2015 | $57,071,000 | +578.6% | 3,968,772 | +322.4% | 0.11% | +575.0% |
Q1 2015 | $8,410,000 | -24.5% | 939,664 | -48.5% | 0.02% | -30.4% |
Q4 2014 | $11,134,000 | +617.9% | 1,825,235 | +1145.9% | 0.02% | +475.0% |
Q3 2014 | $1,551,000 | -11.6% | 146,500 | -1.0% | 0.00% | -20.0% |
Q2 2014 | $1,754,000 | +17.5% | 147,994 | +48.0% | 0.01% | +25.0% |
Q1 2014 | $1,493,000 | +1.8% | 100,000 | 0.0% | 0.00% | -20.0% |
Q4 2013 | $1,467,000 | +25.6% | 100,000 | +45.7% | 0.01% | +25.0% |
Q3 2013 | $1,168,000 | – | 68,635 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
Grace Capital | 49,500 | $228,000 | 0.20% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |